Oxidative stress in Parkinson's disease
- PMID: 12666096
- DOI: 10.1002/ana.10483
Oxidative stress in Parkinson's disease
Abstract
Oxidative stress contributes to the cascade leading to dopamine cell degeneration in Parkinson's disease (PD). However, oxidative stress is intimately linked to other components of the degenerative process, such as mitochondrial dysfunction, excitotoxicity, nitric oxide toxicity and inflammation. It is therefore difficult to determine whether oxidative stress leads to, or is a consequence of, these events. Oxidative damage to lipids, proteins, and DNA occurs in PD, and toxic products of oxidative damage, such as 4-hydroxynonenal (HNE), can react with proteins to impair cell viability. There is convincing evidence for the involvement of nitric oxide that reacts with superoxide to produce peroxynitrite and ultimately hydroxyl radical production. Recently, altered ubiquitination and degradation of proteins have been implicated as key to dopaminergic cell death in PD. Oxidative stress can impair these processes directly, and products of oxidative damage, such as HNE, can damage the 26S proteasome. Furthermore, impairment of proteasomal function leads to free radical generation and oxidative stress. Oxidative stress occurs in idiopathic PD and products of oxidative damage interfere with cellular function, but these form only part of a cascade, and it is not possible to separate them from other events involved in dopaminergic cell death.
Similar articles
-
Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.PLoS One. 2017 Feb 7;12(2):e0171285. doi: 10.1371/journal.pone.0171285. eCollection 2017. PLoS One. 2017. PMID: 28170429 Free PMC article.
-
The role of oxidative stress in Parkinson's disease.J Parkinsons Dis. 2013;3(4):461-91. doi: 10.3233/JPD-130230. J Parkinsons Dis. 2013. PMID: 24252804 Free PMC article. Review.
-
Oxidative mechanisms in nigral cell death in Parkinson's disease.Mov Disord. 1998;13 Suppl 1:24-34. Mov Disord. 1998. PMID: 9613715 Review.
-
The possible role of iron in the etiopathology of Parkinson's disease.Mov Disord. 1993;8(1):1-12. doi: 10.1002/mds.870080102. Mov Disord. 1993. PMID: 8419792 Review.
-
The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.Synapse. 2010 Mar;64(3):241-50. doi: 10.1002/syn.20719. Synapse. 2010. PMID: 19924695
Cited by
-
Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1).Molecules. 2015 May 14;20(5):8742-58. doi: 10.3390/molecules20058742. Molecules. 2015. PMID: 26007177 Free PMC article. Review.
-
May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic Parkinson's disease?Antioxid Redox Signal. 2013 Sep 20;19(9):912-8. doi: 10.1089/ars.2013.5250. Epub 2013 Mar 28. Antioxid Redox Signal. 2013. PMID: 23418747 Free PMC article.
-
Sustained Systemic Antioxidative Effects of Intermittent Theta Burst Stimulation beyond Neurodegeneration: Implications in Therapy in 6-Hydroxydopamine Model of Parkinson's Disease.Antioxidants (Basel). 2024 Feb 8;13(2):218. doi: 10.3390/antiox13020218. Antioxidants (Basel). 2024. PMID: 38397816 Free PMC article.
-
Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's disease.Neurotox Res. 2012 Nov;22(4):355-64. doi: 10.1007/s12640-012-9325-8. Epub 2012 Apr 20. Neurotox Res. 2012. PMID: 22528248
-
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.PLoS One. 2012;7(4):e35397. doi: 10.1371/journal.pone.0035397. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
